Skip to main content
PolyPeptide Group AG logo

PolyPeptide Group AG — Investor Relations & Filings

Ticker · PPGN ISIN · CH1110760852 LEI · 5067007JCKTPOX4G9758 SW Manufacturing
Open in API
Filings indexed 111 across all filing types
Latest filing 2023-04-12 AGM Information
Country CH Switzerland
Listing SW PPGN

About PolyPeptide Group AG

https://www.polypeptide.com/

PolyPeptide Group AG is a Contract Development & Manufacturing Organization (CDMO) specializing in peptide- and oligonucleotide-based active pharmaceutical ingredients (APIs). The company serves the pharmaceutical and biotech sectors by providing a comprehensive range of services that cover all stages of product development, from pre-clinical to commercial manufacturing. Its offerings include both proprietary (custom) and generic GMP-grade peptides. PolyPeptide focuses on innovation in peptide synthesis and manufacturing processes to support the development of therapies for patients.

Recent filings

Filing Released Lang Actions
PolyPeptide gibt Ergebnisse der ordentlichen Generalversammlung 2023 bekannt
AGM Information Classification · 98% confidence The document is a media release titled "PolyPeptide gibt Ergebnisse der ordentlichen Generalversammlung 2023 bekannt" (PolyPeptide announces results of the 2023 Annual General Meeting). It details the outcomes of the shareholder votes, including the re-election of board members and the approval of various management proposals, which are the core activities of an Annual General Meeting (AGM). Although it is a press release announcing the results, the content is specifically about the AGM proceedings and outcomes, making 'AGM Information' (AGM-R) the most appropriate classification over a general 'Report Publication Announcement' (RPA) or 'Regulatory Filing' (RNS), as the primary subject matter is the meeting itself. The document explicitly mentions 'ordentlichen Generalversammlung' (Annual General Meeting).
2023-04-12 German
PolyPeptide appoints Juan-Jose Gonzalez as CEO and announces change of CFO
Board/Management Information Classification · 100% confidence The document is titled 'PolyPeptide appoints Juan-José Gonzalez as CEO and announces change of CFO' and is explicitly labeled as an 'Ad-hoc' release and 'Media release – ad hoc announcement pursuant to Art. 53 LR'. This type of announcement, detailing changes in senior management (CEO and CFO appointments/resignations), directly corresponds to the definition of Board/Management Information (MANG). It is not a full financial report (10-K, IR), an earnings release (ER), or a proxy statement (DEF 14A/PSI).
2023-04-03 English
PolyPeptide appoints Juan-José Gonzalez as CEO and announces change of CFO
Board/Management Information Classification · 100% confidence The document is an 'Ad hoc announcement' dated April 3, 2023, explicitly stating the appointment of a new CEO (Juan-José Gonzalez) and announcing a change in the CFO position. This content directly relates to changes in the company's senior management team. According to the definitions, 'Board/Management Information (Code: MANG)' covers the 'Announcement of changes in the company's board of directors or senior management.' The document is not a full annual report (10-K), an earnings release (ER), or a transcript (CT). Therefore, MANG is the most appropriate classification.
2023-04-03 English
PolyPeptide ernennt Juan-José Gonzalez zum CEO und meldet Wechsel des CFO
Board/Management Information Classification · 100% confidence The document is explicitly titled 'Ad hoc-Mitteilung gemäss Art. 53 KR' (Ad hoc announcement pursuant to Art. 53 KR) and its primary content announces significant changes in senior management: the appointment of a new CEO (Juan-José Gonzalez) and a change in the CFO role. This directly corresponds to the definition of Board/Management Information (MANG), which covers announcements of changes in senior management. Although it is an 'Ad hoc-Mitteilung' (which might sometimes fall under RNS), the specific subject matter (CEO/CFO change) makes MANG the most precise classification. The document length (8161 chars) is substantial enough that it is the announcement/report itself, not just a brief notice pointing to another document.
2023-04-03 German
PolyPeptide publishes invitation to the annual General Meeting 2023
AGM Information Classification · 99% confidence The document explicitly states in the title and body: "PolyPeptide publishes invitation to the annual General Meeting 2023". It details the date, location, and agenda items for the upcoming AGM, including board re-elections and proposals regarding the Articles of Association and compensation. This content directly corresponds to the definition of AGM Information.
2023-03-22 English
PolyPeptide publishes invitation to the annual General Meeting 2023
AGM Information Classification · 99% confidence The document explicitly states, 'PolyPeptide publishes invitation to the annual General Meeting 2023' and details the date, location, and agenda items for the 'annual General Meeting' (AGM 2023). Key items mentioned include the re-election of the Board of Directors and proposals regarding the Articles of Association. This content directly relates to the materials and announcements associated with an Annual General Meeting. Therefore, the classification is AGM-R.
2023-03-22 English

Browse filings by year

6 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.